Fat-Based Treatment Shows Promise for Knee Arthritis
Jack K. Haberl, Nathan S. Hogaboom, Gerard A. Malanga · Biologic Orthopedic Journal · 2020
Your Own Fat Cells May Help Fight Knee Inflammation
If you have knee osteoarthritis, you know the frustration of limited options. Physical therapy and anti-inflammatory medications don't treat the root cause. Joint replacement surgery carries risks and may not suit everyone. This review examines an emerging option: using processed fat tissue from your own body to address the underlying inflammation driving your knee pain.
Knee osteoarthritis isn't simply "wear and tear." It involves complex inflammatory processes that break down cartilage and damage joint tissue. Researchers are now exploring how cells from your own fat tissue might help interrupt this destructive cycle.
Fat Tissue Contains Powerful Healing Cells
Your body's fat tissue is rich in mesenchymal stromal cells (MSCs)—regenerative cells that can develop into muscle, bone, and cartilage. These cells come from "pericytes," helper cells found near blood vessels in fat tissue. Compared to cells taken from bone marrow, fat-derived cells:
Exist in higher numbers per tissue sample
Multiply more quickly when processed
Remain healthier during laboratory expansion
This makes fat tissue an attractive source for regenerative treatments targeting knee arthritis.
Two Methods Extract Healing Cells From Fat
Doctors can harvest these beneficial cells using two main approaches. The first is micro-fragmentation, where fat is gently broken into tiny pieces. This method preserves the tissue's natural structure and meets FDA requirements for same-day clinical use. The Lipogems® system uses this approach.
The second method uses enzymes to separate cells from fat tissue. This produces more cells but faces stricter FDA regulations. Both techniques aim to concentrate the regenerative cells that may help your knee heal.
These Cells Work by Calming Inflammation
The review explains how fat-derived cells combat arthritis at the cellular level. In osteoarthritis, inflammatory chemicals trigger enzymes that destroy cartilage. The regenerative cells from fat tissue release growth factors and anti-inflammatory substances. These help:
Reduce harmful inflammation in the joint
Protect remaining cartilage from further damage
Support the body's natural repair processes
This "immunomodulatory" effect means the cells help regulate your immune system rather than simply adding new tissue.
Research Supports Safety and Effectiveness
The review examined studies ranging from animal research to human trials. The findings suggest that fat-derived cell treatments are generally safe. They also show potential benefits for pain relief and improved joint function. Patients who haven't responded to conservative treatments—and who aren't ready for surgery—may find this approach worth considering.
However, researchers note that more studies are needed. Questions remain about the ideal number of cells to inject, the best processing methods, and which patients benefit most.
This Option May Fill a Treatment Gap
By 2040, nearly 78 million American adults will have arthritis. Almost half will experience activity limitations. Current treatments either mask symptoms or require major surgery. Fat-derived cell therapy offers a middle path. It addresses the underlying inflammatory processes while avoiding surgical risks like blood clots, infection, or nerve injury.
Younger patients especially may benefit. Those under 50 often worry about needing revision surgery later in life. A regenerative approach could delay or potentially prevent the need for joint replacement.
---
Source: Haberl et al., Biologic Orthopedic Journal, 2020.
Original Publication
Chemical Profile and Clinical Efficacy of Adipose-Derived Mesenchymal Stromal Cell Therapy in the Treatment of Knee Osteoarthritis
Jack K. Haberl, Nathan S. Hogaboom, Gerard A. Malanga · Biologic Orthopedic Journal · 2020
Intra-articular injections of adipose-derived mesenchymal stromal cells (AD-MSCs) have emerged as a regenerative therapy to combat the progression of knee osteoarthritis (OA). These multipotent cells have been shown to alter the inflammatory processes inside the knee joint at the cellular level, thus creating a treatment option that both modifies the underlying causes of OA and benefits those who are not surgical candidates. This review article serves to present the following objectives: (1) to summarize the techniques used to harvest AD-MSCs, via micro-fragmentation and enzymatic processing, (2) to characterize the chemical profile and immunomodulatory role of these cells from the current literature, (3) to comprehensively review the clinical efficacy of these interventions, from animal to human studies that investigate the safety concerns, biomolecular changes, and key functional outcomes, and (4) to present areas of future research needed to optimize these interventional regenerative therapies in the treatment of knee OA.